Save 20% on Press Releases and More with NNW Prime! Click to View Details
ThursdayJan 26, 2023 11:55 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Virtual R&D Day

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has scheduled a virtual R&D Day for Feb. 28, 2023; the event is scheduled from 10 to 11:30 a.m. ET. The Cybin leadership team is slated to host the event, which will include an update on the company’s development pipeline of differentiated psychedelic-based therapeutics, including CYB003, which is being evaluated for the treatment of major depressive disorder, and CYB004, which is being evaluated for the treatment of generalized anxiety disorder. According to the announcement, the event will feature an interim readout from CYBN’s ongoing phase 1/2a…

Continue Reading

ThursdayJan 26, 2023 11:27 am

NetworkNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports on Special Shareholder Meeting, Announces Key New Hires

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is releasing results from its reconvened Special Meeting of Stockholders. The meeting, which was held on Jan. 25, 2023, included several proxy proposals on the agenda; MULN is reporting that all proposals were approved. According to the announcement, the company has no current plans to effect a reverse split. In addition, the company has until March 6, 2023, to meet the $1 minimum bid requirement established by NASDAQ. Based on the report, if that share price isn’t met, MULN will seek an extension from NASDAQ to meet the required threshold, which would…

Continue Reading

ThursdayJan 26, 2023 10:53 am

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Year-End Webcast Review

Flora Growth (NASDAQ: FLGC), a leading outdoor grower, manufacturer and distributor of cannabis products and brands worldwide, has scheduled a webcast to provide an overview of the company’s operational milestones achieved in 2022. The year-end review is slated for Jan. 30, 2023, and will begin at 4:30 p.m. ET. The webinar, which will be prerecorded, will feature Flora Growth chair and CEO Luis Merchan, who will discuss the company’s 2022 operational performance; Merchan will also talk about the company’s 2023 revenue guidance. Those who attend the event will receive a recording of the webcast after it is concluded; a recording…

Continue Reading

WednesdayJan 25, 2023 12:55 pm

NetworkNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Advances Novel Drug Candidate in Treating Alzheimer’s Symptoms

India Globalization Capital (NYSE American: IGC), in a historic first, has begun phase 2 clinical trials evaluating its flagship drug candidate, IGC-AD1, for the treatment of agitation in dementia from Alzheimer’s disease. “Company officials noted that, to their knowledge, this is the first natural low-dose THC-based compound to enter human trials for the treatment of symptoms such as agitation in dementia from Alzheimer’s disease. Currently there is no FDA-approved medication to treat agitation in Alzheimer’s,” reads a recent article. The piece quotes IGC CEO Ram Mukunda, who states, “We believe IGC-AD1 has the potential to revolutionize the treatment of the…

Continue Reading

WednesdayJan 25, 2023 12:44 pm

NetworkNewsBreaks – CISO Global Inc. (NASDAQ: CISO) CEO Discusses Top-down Culture of Cybersecurity in ‘Shrimp Tank’ Interview

CISO Global (NASDAQ: CISO), an industry leader in managed cybersecurity and compliance services, was featured on a recent episode of “The Shrimp Tank.” The company’s CEO David Jemmett joined podcast host Ted Jenkin to discuss CISO Global’s approach to cybersecurity, explaining that successful cybersecurity must be woven into the fabric of an organization, encompassing and transforming the entity’s culture. During the interview, Jemmett shared that, although cybersecurity has become a well-known subject in today’s business world, surprisingly few companies are doing enough about this very real threat. “A lot of folks are not addressing [cybersecurity]… They don’t want to know…

Continue Reading

WednesdayJan 25, 2023 12:37 pm

NetworkNewsBreaks — IBN Launches PR+ Client Partner Solution

IBN, a multifaceted financial news and publishing company for private and public entities, has unveiled its newest offering: Public Relations Plus (“PR+”). According to the announcement, the new program will create momentum and deliver a positive impact for IBN’s local, national and international partner organizations. IBN client partners that participate in PR+ will enjoy a number benefits, including consultations to discuss and better identify needs, goals and strategies; targeted research and development with industry-specific media lists that include names of journalists covering specific industries; and pitch writing, development and distribution to targeted media contacts. In addition, the program provides message…

Continue Reading

WednesdayJan 25, 2023 11:39 am

NetworkNewsBreaks – MetAlert Inc. (MLRT) Announces Launch of Its Next-Gen SmartSole in Sweden

MetAlert (OTC: MLRT) today announced the launch of its new 4G GPS SmartSole in Sweden through its distribution partner Posifon AB. The upgraded GPS SmartSole introduction will be an important part of the national service agreement Posifon recently secured with major municipalities across Sweden related to providing home care, personal tracking and security for seniors. Initial shipments of the GPS SmartSole will be distributed to health care organizations, from memory care clinics to hospitals and social care organizations throughout Sweden. “We are excited to launch this next generation 4G Cat M1 GPS SmartSole in one of Europe’s most advanced health…

Continue Reading

WednesdayJan 25, 2023 10:57 am

NetworkNewsBreaks – DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) to Host Q4 and FY 2022 Earnings Call

DoubleDown Interactive (NASDAQ: DDI), a leading gaming company delivering unique player experiences across a variety of genres, today announced that it will hold a conference call at 5:00 p.m. Eastern Time on Tuesday, Feb. 7, 2023, to discuss its results for the fourth quarter and full year ended Dec. 31, 2022. DoubleDown management will host a presentation followed by a question-and-answer period. Interested parties should visit https://nnw.fm/qmkW9 to register for the call, after which they will be sent dial-in details and a unique access code. Attendees are asked to register a minimum of 15 minutes prior to the start of…

Continue Reading

WednesdayJan 25, 2023 10:27 am

NetworkNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) $4.1M Placements Supported by Aegis Capital Corp. as Exclusive Placement Agent

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, recently announced the closing of both a registered direct and a private placement; the placements totaled approximately $4.1 million. Aegis Capital Corp. acted as exclusive placement agent for those placements. In the wealth management and investment banking business since 1984, Aegis has built a reputation for offering corporate finance and strategic advisory services to public and private companies across multiple sectors and regions. In addition, the company offers expert research and sales and trading services to institutional investors. Aegis provides a conflict-free service platform as well as…

Continue Reading

TuesdayJan 24, 2023 11:58 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses ‘Lifeblood’ of Phase 2 Berubicin Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biopharmaceutical company focused on developing novel treatments for primary and metastatic cancers in the brain and central nervous system, is enrolling patients in a phase 2 trial to evaluate the efficacy of its flagship drug candidate. The potentially pivotal trial will evaluate Berubicin for the treatment of glioblastoma multiforme (“GBM”), an aggressive brain tumor with an average overall survival rate of only 10-12 months. The company’s Chief Executive Officer John Climaco recently participated in the Virtual Investor “Ask the CEO” Event and discussed that enrollment in the trial was approaching 70 patients against a…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000